¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"complement binding reaction"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
complement-dependent cytotoxicity
º¸Ã¼ÀÇÁ¸¼¼Æ÷µ¶¼º
complement-fixing antibody
º¸Ã¼°áÇÕÇ×ü, µµ¿òü°áÇÕÇ×ü
complement-induced
º¸Ã¼À¯µµ-
complement-mediated
º¸Ã¼¸Å°³-
complement-mediated cytotoxicity
º¸Ã¼¸Å°³¼¼Æ÷µ¶¼º
dominant complement
¿ì¼ºº¸Ã¼
antibody-binding site
Ç×ü°áÇÕºÎÀ§
antigen binding capacity
Ç׿ø°áÇÕ´É
antigen binding fragment
Ç׿ø°áÇÕºÎÀ§
antigen binding receptor
Ç׿ø°áÇÕ¼ö¿ëü
antigen-binding site
Ç׿ø°áÇÕºÎÀ§
androgen binding protein
¾Èµå·Î°Õ°áÇմܹéÁú
binding
1. ¹À½ 2. °áÇÕ
binding energy
°áÇÕ¿¡³ÊÁö
binding orbit
°áÇձ˵µ
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
antigen-antibody reaction
Ç׿øÇ×ü¹ÝÀÀ
anxiety reaction
ºÒ¾È¹ÝÀÀ
cascade reaction
¿¬¼âÁõÆø¹ÝÀÀ
chain reaction
¿¬¼â¹ÝÀÀ
cross reaction
±³Â÷¹ÝÀÀ
delayed reaction
Áö¿¬¹ÝÀÀ
graft versus host reaction
ÀÌ½ÄÆí´ë¼÷ÁÖ¹ÝÀÀ
inhibition reaction
¾ïÁ¦¹ÝÀÀ
initial reaction
Ãʱâ¹ÝÀÀ
late reaction
(¢¡delayed reaction) Áö¿¬¹ÝÀÀ
periosteal reaction
»À¸·¹ÝÀÀ, °ñ¸·¹ÝÀÀ
phobic reaction
°øÆ÷¹ÝÀÀ
polymerase chain reaction
ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ, ÁßÇÕ¿¬¼â¹ÝÀÀ
pyrogenic reaction
¹ß¿¹ÝÀÀ
rejection reaction
°ÅºÎ¹ÝÀÀ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
cortisol-binding globulin
ÄÚ¸£Æ¼¼Ö°áÇÕ±Û·Îºí¸°
iron-binding capacity
ö°áÇÕ´É
gonadal steroid-binding globulin
»ý½Ä»ù½ºÅ×·ÎÀ̵å°áÇձ۷κҸ°
sex hormone-binding globulin
¼ºÈ£¸£¸ó°áÇÕ±Û·Îºí¸°
testosterone-binding globulin
Å×½ºÅ佺Å׷аáÇձ۷κҸ°
thyroxine-binding globulin
Ƽ·Ï½Å°áÇÕ±Û·Îºí¸°
iron binding protein
ö°áÇմܹéÁú
olfactory binding protein
Èİ¢°áÇմܹé
orthodontic binding wire
±³Á¤¿ë¹±âö»ç, ±³Á¤¿ë°áÂû¼±
alternative complement pathway
º¸Ã¼´ëü°æ·Î, µµ¿òü´ëü°æ·Î
complement activation
µµ¿òüȰ¼º, º¸Ã¼È°¼º
complement-fixing antibody
µµ¿òü°áÇÕÇ×ü, º¸Ã¼°áÇÕÇ×ü
complement
µµ¿òü, º¸Ã¼
complement-induced
(¢¡complement-mediated) µµ¿òü¸Å°³-
complement-mediated
µµ¿òü¸Å°³-
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
IBC= iron binding capacity
ö°áÇÕ´É.
Langmuir expression in drug-antibody binding
¾à¹°-Ç×ü °áÇÕ¿¡¼ÀÇ ¶û¹¿¸£Ç¥Çö
TBG => thyroxine binding globulin
ŸÀ̷ϽаáÇÕ ±Û·ÎºÎ¸°
TBPA => thyroxine binding prealbumin
ŸÀ̷ϽŰáÇÕÀü¾ËºÎ¹Î
TIBC => total iron binding capacity
ÃÑö°áÇÕ´É
UIBC => unsaturated iron binding capacity
ºÒÆ÷Èö°áÇÕ´É
actin-binding protein
¾×ƾ °áÇմܹé(¡Ì¿ùêÓ±ÛÜ)
androgen- binding protein
¸¸¼ºÈ£¸£¸ó °áÇմܹé
antibody binding site
Ç×ü°áÇÕºÎÀ§
antigen binding capacity
Ç׿ø°áÇÕ´É(¡Ì¿ùêÒö).
antigen binding fragment
Ç׿ø°áÇÕºÎÀ§
antigen binding receptor
Ç׿ø°áÇÕ¼ö¿ëü
antigen binding site
Ç׿ø°áÇÕºÎÀ§
human zona binding assay
»ç¶÷Á¤ÀÚ Åõ¸í´ëºÎÂø°Ë»ç
plasma protein binding
Ç÷Àå´Ü¹é°áÇÕ.
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
binding
°áÇÕ(Ì¿ùê)
binding
¹À½, °áÇÕ.
binding activity
°áÇÕȰ¼º(Ì¿ùêüÀàõ).
binding activity
¸é¿ª°áÇÕȰ¼º(Ì¿ùêüÀàõ).
binding affinity
°áÇÕģȼº(Ì¿ùêöÑûúàõ)
binding displacement analysis
°áÇÕº¯À§ºÐ¼®(Ì¿ùêܨêÈÝÂà°).
binding energy
°áÇÕ¿¡³ÊÁö
binding energy
°áÇÕ(Ì¿ùê)¿¡³ÊÁö
binding orbit
°áÇձ˵µ(Ì¿ùêÏùÔ³).
binding site
°áÇÕºÎÀ§.
binding site
°á ÇÕºÎÀ§.
calcium-binding protein
Ä®½· °áÇմܹé(Ì¿ùêÓ±ÛÜ)
cap binding protein
ĸ°áÇմܹéÁú
cell growth,ligand receptor binding
¸®°£µå¼ö¿ë±â°áÇÕ (¡áôé»ÐïÌ¿ùê)
cellular retinol-binding protein
¼¼Æ÷³» ·¹Æ¼³î °áÇմܹé
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½